跳转至内容
Merck
CN

Endothelial cells enhance the migration of bovine meniscus cells.

Arthritis & rheumatology (Hoboken, N.J.) (2014-10-14)
Xiaoning Yuan, George M Eng, Derya E Arkonac, Pen-Hsiu Grace Chao, Gordana Vunjak-Novakovic
摘要

To study the interactions between vascular endothelial cells and meniscal fibrochondrocytes from the inner avascular and outer vascular regions of the meniscus and to identify angiogenic factors that enhance cell migration and integrative repair. Bovine meniscal fibrochondrocytes (bMFCs) from the inner and outer regions of meniscus were cultured for 7 days with or without human umbilical vein endothelial cells (HUVECs) in a micropatterned 3-dimensional hydrogel system for assessment of cell migration. Angiogenic factors secreted by HUVECs were probed for their role in paracrine mechanisms governing bMFC migration and applied to a full-thickness defect model of meniscal repair in explants from the inner and outer meniscal regions over 4 weeks. Endothelial cells enhanced the migration of inner and outer bMFCs in the micropatterned system via endothelin 1 (ET-1) signaling. Supplementation with ET-1 significantly enhanced the integration strength of full-thickness defects in the inner and outer explants, as well as cell migration at the macroscale level, as compared to controls without ET-1 treatment. This study is the first to show that bMFCs from both the avascular and vascular regions of the meniscus respond to the presence of endothelial cells with increased migration. Paracrine signaling by endothelial cells regulates the bMFCs differentially by region, but we identified ET-1 as an angiogenic factor that stimulates the migration of inner and outer cells at the microscale level and the integrative repair of inner and outer explants at the macroscale level. These findings reveal the regional interactions between the vasculature and MFCs, and suggest ET-1 as a potential new treatment for avascular meniscus injuries in order to prevent the development of osteoarthritis.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioReagent, suitable for cell culture
Sigma-Aldrich
盐酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, Sigma Grade, ≥99% (TLC), powder
Sigma-Aldrich
盐酸, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
盐酸, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
盐酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., fuming, ≥37%, APHA: ≤10
Sigma-Aldrich
盐酸, 36.5-38.0%, BioReagent, Molecular Biology
Supelco
盐酸 溶液, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
乙醇胺, ≥99%
Sigma-Aldrich
乙醇胺, ≥98%
Sigma-Aldrich
乙醇胺, purified by redistillation, ≥99.5%
Sigma-Aldrich
盐酸 溶液, for amino acid analysis, ~6 M in H2O
Sigma-Aldrich
乙醇胺, ACS reagent, ≥99.0%
Sigma-Aldrich
八甲基三硅氧烷, 98%
Supelco
氯化氢 – 甲醇 溶液, ~1.25 m HCl (T), derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
聚二甲基硅氧烷, viscosity 1.0 cSt (25 °C)
USP
乙酰半胱氨酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
盐酸 溶液, 32 wt. % in H2O, FCC
Supelco
N-乙酰基-L-半胱氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioXtra, ≥99% (TLC)
Sigma-Aldrich
氯化氢 溶液, 1.0 M in acetic acid
Sigma-Aldrich
乙醇胺, liquid, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
盐酸, puriss., 24.5-26.0%
Supelco
Hydrogen chloride – ethanol, ~1.25 M HCl, derivatization grade (GC derivatization), LiChropur
Supelco
氯化氢 – 2-丙醇 溶液, ~1.25 M HCl (T), derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
乙醇胺, puriss. p.a., ACS reagent, ≥99.0% (GC/NT)
Sigma-Aldrich
聚二甲基硅氧烷, viscosity 0.65 cSt (25 °C)